A. Tolkushin, M. Hołownia-Voloskova, E. A. Luchinin, A. Zavyalov
{"title":"2019年莫斯科某些淋巴和造血组织恶性肿瘤患者优先药物提供框架内的药物消费审查","authors":"A. Tolkushin, M. Hołownia-Voloskova, E. A. Luchinin, A. Zavyalov","doi":"10.30809/solo.3.2021.3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"REVIEW OF DRUG CONSUMPTION WITHIN THEFRAMEWORK OF PREFERENTIAL DRUG PROVISION FOR PATIENTS WITH CERTAIN MALIGNANT NEOPLASMS OF LYMPHATIC AND HEMATOPOIETIC TISSUES IN MOSCOW IN 2019\",\"authors\":\"A. Tolkushin, M. Hołownia-Voloskova, E. A. Luchinin, A. Zavyalov\",\"doi\":\"10.30809/solo.3.2021.3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":266512,\"journal\":{\"name\":\"Modern organization of drug supply\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern organization of drug supply\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.30809/solo.3.2021.3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern organization of drug supply","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30809/solo.3.2021.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
REVIEW OF DRUG CONSUMPTION WITHIN THEFRAMEWORK OF PREFERENTIAL DRUG PROVISION FOR PATIENTS WITH CERTAIN MALIGNANT NEOPLASMS OF LYMPHATIC AND HEMATOPOIETIC TISSUES IN MOSCOW IN 2019